Feb 7 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2019 Dec 31, 2018 Mar 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 389 mln 578 mln 670 mln
(-32.6 pct) (+14.6 pct) (-14.2 pct)
Operating loss 298 mln loss 65 mln loss 510 mln
Recurring loss 350 mln loss 62 mln loss 640 mln
Net loss 337 mln loss 76 mln loss 655 mln
EPS loss 38.67 yen loss 9.03 yen loss 75.08 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T